UB Paderborn / Katalog / Suche / in CDI

The utility of radiological imaging in nonalcoholic fatty liver disease

Gastroenterology (New York, N.Y. 1943), 2002-09, Vol.123 (3), p.745-750

2002

Link zum Volltext

Verfügbarkeit prüfen

Hepatic encephalopathy

European journal of gastroenterology & hepatology, 2001-04, Vol.13 (4), p.325-334

2001

Link zum Volltext

Verfügbarkeit prüfen

MARS--does it stand the test of time?

Metabolic brain disease, 2004-12, Vol.19 (3-4), p.223-228

2004

Link zum Volltext

Verfügbarkeit prüfen

Correlation between ammonia levels and the severity of hepatic encephalopathy

The American journal of medicine, 2003-02, Vol.114 (3), p.188-193

2003

Link zum Volltext

Verfügbarkeit prüfen

Rifaximin has the potential to prevent complications of cirrhosis

Therapeutic advances in gastroenterology, 2018-01, Vol.11, p.1756284818800307-1756284818800307

2018

Link zum Volltext

Verfügbarkeit prüfen

Surprisingly small effect of antiviral treatment in patients with hepatitis C

Annals of internal medicine, 2002-02, Vol.136 (4), p.288

2002

Link zum Volltext

Verfügbarkeit prüfen

Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study

The American journal of gastroenterology, 2003-06, Vol.98 (6), p.1391-1394

2003

Link zum Volltext

Verfügbarkeit prüfen

Natural Benzodiazepines and Hepatic Encephalopathy

Seminars in liver disease, 1996, Vol.16 (3), p.255-264

1996

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease

The American journal of gastroenterology, 2000, Vol.95 (10), p.2936-2939

2000

Link zum Volltext

Verfügbarkeit prüfen

Neurological deficits in "awake" cirrhotic patients on hepatic encephalopathy treatment: Missed metabolic or metal disorder?

Gastroenterology (New York, N.Y. 1943), 1996-07, Vol.111 (1), p.256-257

1996

Link zum Volltext

Verfügbarkeit prüfen

Obesity and Non-Alcoholic Fatty Liver Disease in Chronic Hepatitis C

Journal of clinical gastroenterology, 2004-09, Vol.38 (8), p.705-709

2004

Link zum Volltext

Verfügbarkeit prüfen

Protein restriction in hepatic encephalopathy: necessary evil or illogical dogma?

Journal of hepatology, 2004-07, Vol.41 (1), p.147-148

2004

Link zum Volltext

Verfügbarkeit prüfen

Improving compliance with postpolypectomy surveillance guidelines: an interventional study using a continuous quality improvement initiative

Gastrointestinal endoscopy, 2006, Vol.63 (1), p.97-103

2006

Link zum Volltext

Verfügbarkeit prüfen

Use of tegaserod along with polyethylene glycol electrolyte solution for colonoscopy bowel preparation: a prospective, randomized, double‐blind, placebo‐controlled study

Alimentary pharmacology & therapeutics, 2006-03, Vol.23 (5), p.669-674

2006

Link zum Volltext

Verfügbarkeit prüfen

Completion of upper endoscopic procedures despite paradoxical reaction to midazolam: a role for flumazenil?

The American journal of gastroenterology, 2000-03, Vol.95 (3), p.809-811

2000

Link zum Volltext

Verfügbarkeit prüfen

Is acarbose an effective drug for treating patients with cirrhosis and hepatic encephalopathy?

Nature clinical practice. Gastroenterology & hepatology, 2005-06, Vol.2 (6), p.264-265

2005

Link zum Volltext

Verfügbarkeit prüfen

Primary prophylaxis of variceal bleeding in cirrhosis: A cost- effectiveness analysis

Gastroenterology (New York, N.Y. 1943), 1997-02, Vol.112 (2), p.473-482

1997

Link zum Volltext

Verfügbarkeit prüfen

A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy

Journal of hepatology, 2001, Vol.34 (1), p.128-133

2001

Link zum Volltext

Verfügbarkeit prüfen

Branched Chain Amino Acid Supplements in Liver Disease

Clinical gastroenterology and hepatology, 2005-07, Vol.3 (7), p.631-632

2005

Link zum Volltext

Verfügbarkeit prüfen

Resolution of Hereditary Hemorrhagic Telangiectasia and Anemia With Prolonged α-interferon Therapy for Chronic Hepatitis C

Journal of clinical gastroenterology, 2004-04, Vol.38 (4), p.377-379

2004

Link zum Volltext

Verfügbarkeit prüfen

Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B

Gastroenterology (New York, N.Y. 1943), 1988-11, Vol.95 (5), p.1318-1325

1988

Link zum Volltext

Verfügbarkeit prüfen

Early Hepatitis C virus–RNA responses predict interferon treatment outcomes in chronic hepatitis C

Hepatology (Baltimore, Md.), 1998-11, Vol.28 (5), p.1411-1415

1998

Link zum Volltext

Verfügbarkeit prüfen

Pegylated interferon alpha-2b, ribavirin and amantadine for chronic hepatitis C

Digestive diseases and sciences, 2005-05, Vol.50 (5), p.970-975

2005

Link zum Volltext

Verfügbarkeit prüfen

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

The New England journal of medicine, 1986-12, Vol.315 (25), p.1575-1578

1986

Link zum Volltext

Verfügbarkeit prüfen

Measurements of total body and extracellular water in cirrhotic patients with and without ascites

Hepatology (Baltimore, Md.), 1991-12, Vol.14 (6), p.1102-1111

1991

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

The utility of radiological imaging in nonalcoholic fatty liver disease

Hepatic encephalopathy

MARS--does it stand the test of time?

Correlation between ammonia levels and the severity of hepatic encephalopathy

Rifaximin has the potential to prevent complications of cirrhosis

Surprisingly small effect of antiviral treatment in patients with hepatitis C

Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study

Natural Benzodiazepines and Hepatic Encephalopathy

Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease

Neurological deficits in "awake" cirrhotic patients on hepatic encephalopathy treatment: Missed metabolic or metal disorder?

Obesity and Non-Alcoholic Fatty Liver Disease in Chronic Hepatitis C

Protein restriction in hepatic encephalopathy: necessary evil or illogical dogma?

Improving compliance with postpolypectomy surveillance guidelines: an interventional study using a continuous quality improvement initiative

Use of tegaserod along with polyethylene glycol electrolyte solution for colonoscopy bowel preparation: a prospective, randomized, double‐blind, placebo‐controlled study

Completion of upper endoscopic procedures despite paradoxical reaction to midazolam: a role for flumazenil?

Is acarbose an effective drug for treating patients with cirrhosis and hepatic encephalopathy?

Primary prophylaxis of variceal bleeding in cirrhosis: A cost- effectiveness analysis

A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy

Branched Chain Amino Acid Supplements in Liver Disease

Resolution of Hereditary Hemorrhagic Telangiectasia and Anemia With Prolonged α-interferon Therapy for Chronic Hepatitis C

Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B

Early Hepatitis C virus–RNA responses predict interferon treatment outcomes in chronic hepatitis C

Pegylated interferon alpha-2b, ribavirin and amantadine for chronic hepatitis C

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

Measurements of total body and extracellular water in cirrhotic patients with and without ascites

Suchergebnisse filtern